1 completed, 1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Mucopolysaccharidosis Type 3 B: new trials by email Literature Review of Mucopolysaccharidosis Type 3 B trials Research Report on Mucopolysaccharidosis Type 3 B
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gene Transfer Clinical Trial for Mucopolysaccharidosis (MPS) IIIB rAAV9.CMV.hNAGLU - Mucopolysaccharidosis Type 3 B | Phase 1 / Phase 2 | Terminated | Abeona Therapeutics, Inc | 11 | 2017-10-16 | 2022-05-05 |
| A Study of Mucopolysaccharidosis Type IIIB (MPS IIIB) Mucopolysaccharidosis Type IIIB, Mucopolysaccharidosis Type 3 B | Completed | Allievex Corporation | 22 | 2015-11-01 | 2020-03-06 |
Carbohydrate Metabolism, Inborn Errors (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Connective Tissue Diseases (2) · Genetic Diseases, Inborn (2) · Lysosomal Storage Diseases (2) · Metabolic Diseases (2) · Metabolism, Inborn Errors (2) · Mucinoses (2) · Mucopolysaccharidoses (2) · Nutritional and Metabolic Diseases (2) · Skin and Connective Tissue Diseases (2)
Abeona Therapeutics, Inc (1) · Allievex Corporation (1)
Germany (2) · Spain (2) · United States (2) · Australia (1) · Colombia (1) · France (1) · Taiwan (1) · Turkey (Türkiye) (1) · United Kingdom (1)